Delpharm Boucherville Canada Inc.
Quebec · Canada
Key Differentiator
STRATEGICALLY CRITICAL for Canadian healthcare — largest sterile injectable facility in Canada
Core Services
Market Intelligence
STRATEGICALLY CRITICAL for Canadian healthcare — largest sterile injectable facility in Canada. $220M transformation by 2031 = world-class facility. Key partner: Sandoz (renewed 10-year contract for generic hospital medicines). Canadian pharmaceutical sovereignty pillar.
Website
https://www.delpharm.comSimilar Companies
AGC Biologics
Bothell, WA (US HQ); Boulder, CO; Longmont, CO ·
Proprietary CHEF1® expression system
ARSI Canada Inc.
Mississauga, ON (Unit 16, 6800 Kitimat Rd) · Custom synthesis, analytical development, drug development
Mississauga CRO
Actylis (Montreal Operations)
Quebec ·
Global API and excipient supplier with Canadian manufacturing
Ajinomoto Bio-Pharma Services
San Diego, CA; Oss, Netherlands ·
Proprietary AJICAP™ site-specific ADC bioconjugation technology
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.